Author

Harsha Pulakkat Muralidharan

Indian Institute of Science BangaloreORCID 0009-0004-5903-6187Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cancer Biology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Organism:human· 2 Research Focus:cancer & tumor microenvironment· 1 Assay:DNA methylation· 1 Research Focus:gene regulatory network inference· 1

Frequent Co-Authors

Arun KumariD· 2 shared Champaka Gopal· 2 shared Radha Mishra· 2 shared Dhanashree Anil More· 1 shared Kodaganur Srinivasachar Gopinath· 1 shared Nivedita SinghiD· 1 shared

Activity by Year

2024-2025 · peak 1/yr

Co-Author Collaboration Network

6 top collaborators · 15 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

Arun KumarORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Cancer BiologybioRxivPreprintApr 26, 2025

miR-631 suppresses oncogene RAB11A in oral squamous cell carcinoma

Harsha Pulakkat Muralidharan, Radha Mishra, Champaka Gopal, Arun Kumar

This study identifies miR-631 as a tumor suppressor in OSCC that targets RAB11A, reduces proliferation, and promotes apoptosis, with potential therapeutic applications.

DOI 10.1101/2025.04.26.650806

humanexperimental assay

𝕏 PostBluesky

Cancer BiologyPLoS ONEPeer-reviewedMay 23, 2024

Intronic miR-6741-3p is involved in oral squamous cell carcinoma pathogenesis by targeting the oncogene SRSF3

Dhanashree Anil More, Nivedita Singh, Radha Mishra…·Arun Kumar

This study identifies miR-6741-3p as a tumor suppressor in oral squamous cell carcinoma by targeting SRSF3, showing its potential as a therapeutic target.

8 citations

humanDNA methylation

𝕏 PostBluesky